SARS CoV 2 Infection: Clinical Trials

20 trials for SARS CoV 2 Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 5 unknown, 3 active not recruiting, 2 not yet recruiting. 20 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 6, Unknown 5, Active not recruiting 3, Not yet recruiting 2, Recruiting 2, Terminated 1, Withdrawn 1

Follow SARS CoV 2 Infection: new trials by email Literature Review of SARS CoV 2 Infection trials Research Report on SARS CoV 2 Infection

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections
Baseline MxA testing, Serial MxA testing, MxA result feedback and antiviral treatment recommendations - Respiratory Viral Infections, Influenza
Not applicableNot yet recruitingCapital Medical University6182026-11-302026-10-23
Clinical Validation of the NowFuture Digital Flu / COVID Test in Anterior Nasal Samples for Over-the-Counter (OTC) Use in Australia
Diagnostic test for SARS-CoV-2, influenza A and influenza B - SARS CoV 2 Infection, Influenza A Virus Infection
Not applicableActive not recruitingBiocrucible Ltd5002026-08-172026-10-06
Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine
RIPH2 - SARS CoV 2 Infection
Not applicableNot yet recruitingCerbaXpert75002024-12-232024-04-15
Eficacia Ventilatoria y Remolacha
Remolacha - SARS CoV 2 Infection, Muscle Disorder
Not applicableUnknownHospital de Mataró302023-11-132024-01-22
Lollipop COVID-19 Testing Study
Lollipop Swab - COVID-19, SARS CoV 2 Infection
Not applicableWithdrawnUniversity of Wisconsin, Madison2023-07-012023-07-27
Use of a Hypochlorous Acid Spray Solution in the Treatment of COVID-19 Patients : COVICONTROL Study .
Spray with Hypochlorous Acid Group, Spray with Placebo Group - SARS CoV 2 Infection
Not applicableUnknownUniversity of Monastir4002023-05-152023-06-26
Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.
Transcranial Direct Current Therapy (tDCS), Sham (No Treatment) - COVID-19, Long COVID
Not applicableRecruitingFundación Universidad Católica de Valencia San Vicente Mártir872023-04-012026-10-15
Hyperbaric Oxygen Therapy Improves Brain Function in Patients With Cognitive Decline After COVID-19 Infection.
hyperbaric oxygen therapy, conventional oxygen therapy - Cognitive Decline, COVID-19
Not applicableUnknownThe First Affiliated Hospital of Zhejiang Chinese Medical University802023-01-292023-02-08
Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations
Humoral immunity - SARS CoV 2 Infection, COVID-19
Not applicableActive not recruitingMaria Goossens3502023-01-232025-06-06
Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19
Sessions of cognitive stimulation - COVID-19, Neuro-Degenerative Disease
Not applicableUnknownFundacin Biomedica Galicia Sur882022-12-142022-12-02
Differential Diagnosis of Persistent COVID-19 by Artificial Intelligence
Experimental tests - COVID-19, Fatigue
Not applicableUnknownFundacin Biomedica Galicia Sur1362022-12-142022-11-29
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
Collection of biological samples - COVID-19, SARS CoV 2 Infection
Not applicableTerminatedCentre Hospitalier Régional d'Orléans92022-12-012024-11-19
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
Levels of inflammatory cytokine ( IL-6) in post-COVID-19 POTS and controls, Levels of inflammatory cytokine ( IL-6) in controls, Effect on inflammation after chronic PNS stimulation - Post-acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS)
Not applicableActive not recruitingVanderbilt University Medical Center602022-06-012026-07-15
Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail
Human IgG1 anti-SARS-CoV-2 antibody cocktail, Placebo - SARS CoV 2 Infection, SARS-CoV-2 Acute Respiratory Disease
Not applicableCompletedChulalongkorn University502022-04-202022-07-07
Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
Enoxaparin Sodium, Bivalirudin - Acute Respiratory Failure, SARS CoV 2 Infection
Not applicableCompletedUniversity Magna Graecia582022-04-202022-08-19
Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)
Placebo Comparator: Sterile Water, 27% Ethanol plus essential oils, 0.075% Cetylpyridinium Chloride - COVID-19, Coronavirus Infection
Not applicableCompletedUniversity of North Carolina, Chapel Hill2302022-01-202024-09-19
Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior
Rhinoswab Junior, Combined nose and throat swab, Saliva swab - SARS CoV 2 Infection, COVID-19
Not applicableCompletedMurdoch Childrens Research Institute3392021-08-262023-02-08
Rutgers Pilot for PREDICT- Patient POC Test
Testing for SARS CoV2 Antigen - SARS CoV 2 Infection
Not applicableCompletedRutgers, The State University of New Jersey142020-12-302024-03-27
Exercise in Child Health
Exercise - Cystic Fibrosis, Sickle Cell Disease
Not applicableRecruitingUniversity of California, Irvine2402020-11-122026-10-02
Anosmia and Covid-19
Olfactory Training - Anosmia, SARS CoV 2 Infection
Not applicableCompletedUniversity College, London632020-06-032022-02-18

Narrower conditions

COVID-19 (20)  ·  Cognitive Dysfunction (2)  ·  Fatigue (2)  ·  Post-Acute COVID-19 Syndrome (2)  ·  Anemia, Sickle Cell (1)  ·  Anosmia (1)  ·  Arthralgia (1)  ·  Chronic Pain (1)  ·  Cluster Headache (1)  ·  Coronavirus Infections (1)  ·  Cystic Fibrosis (1)  ·  Headache Disorders (1)  ·  Influenza, Human (1)  ·  Migraine Disorders (1)  ·  Muscular Diseases (1)

Broader conditions

Coronaviridae Infections (20)  ·  Infections (20)  ·  Lung Diseases (20)  ·  Nidovirales Infections (20)  ·  Pneumonia (20)  ·  Pneumonia, Viral (20)  ·  RNA Virus Infections (20)  ·  Respiratory Tract Diseases (20)  ·  Respiratory Tract Infections (20)  ·  Virus Diseases (20)  ·  Coronavirus Infections (19)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Nervous System Diseases (4)  ·  Signs and Symptoms (4)  ·  Mental Disorders (3)

Interventions

Cetylpyridinium (1)  ·  Diagnostic Tests, Routine (1)  ·  Ethanol (1)  ·  Exercise (1)  ·  Hyperbaric Oxygenation (1)  ·  Immunity, Humoral (1)  ·  Oils, Volatile (1)  ·  Olfactory Training (1)  ·  Transcranial Direct Current Stimulation (1)  ·  bivalirudin (1)  ·  enoxaparin sodium (1)

Sponsors

Fundacin Biomedica Galicia Sur (2)  ·  Biocrucible Ltd (1)  ·  Capital Medical University (1)  ·  Centre Hospitalier Régional d'Orléans (1)  ·  CerbaXpert (1)  ·  Chulalongkorn University (1)  ·  Fundación Universidad Católica de Valencia San Vicente Mártir (1)  ·  Hospital de Mataró (1)  ·  Maria Goossens (1)  ·  Murdoch Childrens Research Institute (1)  ·  Rutgers, The State University of New Jersey (1)  ·  The First Affiliated Hospital of Zhejiang Chinese Medical University (1)  ·  University College, London (1)  ·  University Magna Graecia (1)  ·  University of California, Irvine (1)

Countries

United States (5)  ·  Spain (4)  ·  Australia (2)  ·  China (2)  ·  Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Thailand (1)  ·  Tunisia (1)  ·  United Kingdom (1)

Top investigators

Bin Cao, M.D. (1)  ·  Cecile A Feldman (1)  ·  Cyndya Shibao, M.D (1)  ·  Dhammika Leshan Wannigama, MD PhD (1)  ·  Ellen Wald, MD (1)  ·  Federico Longhini, MD (1)  ·  Jiannong Wu, M.D. (1)  ·  Laura A Jacox, DMD, PhD (1)  ·  Matt Lechner, MD FRCS (1)  ·  Semir Nouira, MD (1)  ·  Shelby O'Connor, MD (1)  ·  Thanarathi Imsuwansr, MD (1)  ·  Thitinan Jongthitinon, MD (1)

Results publications

PMID 34554629, PMID 34763723, PMID 34864935, PMID 36401338, PMID 36962838, PMID 37106344, PMID 37549192, PMID 37730833